News • Deep learning refinement
Colorectal cancer: AI tool improves diagnostic accuracy
Researchers from Finland have developed an artificial intelligence tool for automatic colorectal cancer tissue analysis that outperforms prior methods.
Colon cancer
News • Biomarker-based predictions
AI drives precision oncology for colorectal cancer
For the first time, researchers show that AI-based predictions can deliver comparable results to clinical tests on biopsies of patients with colorectal cancer (CRC).
News • Mysterious mechanism solved
Researchers discover how bowel cancer 'blinds' the immune system
A mystery which has stumped bowel cancer researchers for decades, has been solved by scientists at the Cancer Research UK Beatson Institute and University of Glasgow.
News • Accuracy gain
Bowel cancer: double testing for better detection
Scientists from the University of Edinburgh have found that the accuracy of detecting bowel cancer is increased to almost 100% by carrying out a common test twice rather than once.
News • Oncology & health informatics
Colon cancer: AI tool predicts survival, treatment response
A new artificial intelligence model could bring much-needed clarity to doctors delivering prognoses and deciding on treatments for patients with colorectal cancer.
News • Pregnancy & colorectal cancer
Colorectal cancer in the mother linked to adverse pregnancy outcomes
In a nationwide Swedish study of 207 births to women with an earlier diagnosis of colorectal cancer (CRC), researchers found an increased risk of both maternal and neonatal adverse outcomes.
News • Reduced postoperative complications
Colorectal cancer surgery: gut microbiota helps healing
In a promising study, Canadian researchers have shown for the first time in mice that modifying intestinal flora before surgery could reduce postoperative complications in colorectal cancer patients.
News • Potential of immunotherapy explored
Surgery first for colon cancer? Not so fast, says new study
Immunotherapy prior to surgery is surprisingly effective for patients with a certain type of colorectal cancer (dMMR/MSI-H CRC). These new study results contrast current treatment regimens.
News • Hereditary non-polyposis colorectal cancer
Lynch syndrome: AI improves colorectal cancer screening
Researchers have now found that artificial intelligence (AI) can improve the effectiveness of colonoscopy in the presence of Lynch syndrome.
News • Metastatic recurrence
Researchers discover mechanism responsible for colon cancer relapse
Researchers in Barcelona discovered the population of residual tumour cells responsible for the recurrence of colorectal cancer in other organs after removal of the primary tumour.
News • New treatment approach
Colon cancer: Overcoming chemotherapy resistance
Colorectal cancer is one of the most common cancers. A team from the University of Geneva has found an alternative for patients who have developed resistance to chemotherapy treatments.
Article • Diagnostic assistant systems
AI in endoscopy: helper, trainer – influencer?
Artificial intelligence (AI) is increasing its foothold in endoscopy. Although the algorithms often detect pathologies faster than humans, their use also generates new problems. PD Dr Alexander Hann from the University Hospital Würzburg points out that the use of AI helpers can affect not only the reporting of findings – but also the person making the findings.
News • Prevention measure scrutinised
Colorectal cancer: colonoscopy screening not as effective as previously believed
A randomized study shows colonoscopy screening reduces the risk of colorectal cancer by 18 percent. The reduction is much smaller than experts previously assumed.
News • Better outcomes, fewer costs
Experts propose less invasive bowel cancer treatment approach
New research suggests that providing a break in treatment to patients with advanced bowel cancer could not only benefit a patient’s quality of life but could also help reduce costs.
News • AI approach to colorectal tumors
Deep learning identifies molecular patterns of cancer
A new AI platform can analyze genomic data extremely quickly, picking out key patterns to classify different types of colorectal tumors and improve the drug discovery process.
News • Automated adenoma analysis
AI finds more precancerous polyps than traditional colonoscopy
Colonoscopies performed with AI support may yield an increase in the overall rate of detection of adenoma, or cancerous and precancerous polyps, by 27% in average-risk patients, according to new data.
News • Prevention improvement
Bowel cancer: most cases diagnosed outside of screening programmes
More than 70% of patients with bowel cancer are not diagnosed using screening programmes meaning diagnoses are often made late, when the cancer is at an advanced stage, according to new research.
News • Colorectal cancer study
Covid-19 pandemic slashes CRC diagnoses by over 40%
The number of colorectal cancer (CRC) cases diagnosed fell dramatically by 40% in a year during the Covid-19 pandemic, new research presented at United European Gastroenterology (UEG) Week Virtual 2021 has shown. The research, which was conducted across multiple hospitals in Spain, compared data from the first year of the Covid-19 pandemic with data from the previous year. Of 1,385 cases of CRC…
News • First-of-its-kind study
Computer-assisted colonoscopies reduces rate of missed lesions
Decreasing the rate of missed lesions could translate into fewer cases of colon cancer.
News • Early detection & prevention
Blood-based micro-RNAs indicate colorectal cancer risk
The risk of colorectal cancer can be predicted more accurately by determining seven blood-based micro-RNAs (miRNAs) than by using traditional methods - and can be done so many years before a diagnosis is made. In a current study, researchers from the German Cancer Research Center and the National Center for Tumor Diseases (NCT) Heidelberg show that miRNA profiles provide greater predictive…
News • MSI tumors
Vaccination against hereditary colorectal cancer shows promise
Scientists from the German Cancer Research Center and Heidelberg University Hospital have for the first time been able to delay the development of hereditary colorectal cancer with a protective vaccination. Mice with a hereditary predisposition to colorectal cancer survived significantly longer after vaccination than unvaccinated animals. Combining the vaccination with an anti-inflammatory drug…
News • Health economics
Why certified cancer centers are worth the extra input
Quality assurance in cancer medicine has a reputation for being expensive and involving considerable outlay. For the first time, a cost-effectiveness analysis has now shown that patients treated in certified cancer centers not only survived longer than patients in non-certified hospitals, but also cost less, despite the greater resource commitment required. This was established by health…
News • RAS protein mutation
New treatment approach targets cancer 'Death Star'
A new way to target a mutant protein which can cause the deadliest of cancers in humans has been uncovered by scientists at Leeds. The mutated form of the RAS protein has been referred to as the “Death Star” because of its ability to resist treatments and is found in 96% of pancreatic cancers and 54% of colorectal cancers. RAS is a protein important for health but in its mutated form it can…
News • Oncology early detection tool
Blood test for 50+ types of cancer promising for screening
Final results from a study of a blood test that can detect more than 50 types of cancer have shown that it is accurate enough to be rolled out as a multi-cancer screening test among people at higher risk of the disease, including patients aged 50 years or older, without symptoms. In a paper published in the cancer journal Annals of Oncology, researchers report that the test accurately detected…
News • Chemotherapeutic delivery
Bowel cancer: Nanotechnology offers new hope
Bowel cancer survival rates could be improved if chemotherapy drugs were delivered via tiny nanoparticles to the diseased organs rather than oral treatment. That’s the finding from Indian and Australian scientists who have undertaken the first study, using nanoparticles to target bowel cancer, the third most common cancer in the world and the second most deadliest.
